Andrew Saik joined the Milestone Pharmaceuticals board of directors in July 2024. Mr. Saik has more than 25 years of biopharma finance experience and has participated in over 40 successful mergers and acquisition transactions.

Joseph Papa joined the Milestone Pharmaceuticals Board of Directors in September 2024.

Stuart Duty joined the Milestone Pharmaceuticals board of directors in July 2024. Mr. Duty is an experienced financial executive with over 30 years in finance and investment banking, building leading healthcare teams on multiple platforms with a history of substantial growth in both revenue and personnel.